Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02015728
Title Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications

brain cancer

Therapies

Erlotinib

Everolimus

Dasatinib

Etoposide + Temozolomide

Sorafenib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.